focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksPlethora Solutions Holdings Plc Share News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECT: UK WINNERS & LOSERS: African Barrick Gold Leads FTSE 250 Fallers

Tue, 11th Mar 2014 13:51

(An item published at 1145 GMT mistated the year-earlier period in the Fenner summary and the revenue figures in the Inchcape summary. The correct version follows:)

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.

-------

FTSE 100 - WINNERS

Sports Direct International, up 2.5%. The sports goods retailer said it plans to reward its founder, deputy chairman and biggest shareholder, Mike Ashley, with share options worth more than GBP65 million, money it says is due to him for the company's strong performance as a listed company. Ashley has not been paid for his executive role at the company since the business was listed in February 2007, despite two previous attempts by the board to reward him. Sports Direct said its board had therefore decided to propose to shareholders that he be given options over eight million shares in the company, a further 1.3% stake.

-------

FTSE 100 - LOSERS

WM Morrison Supermarkets, down 1.2%. The food retailer is once again amongst the biggest blue-chip losers Tuesday, having fallen heavily on Monday on a report in the Sunday Telegraph that the supermarket is expected to announce big price cuts with its results on Thurday. Weighing on the stock Tuesday, retail sales growth in the UK declined sharply in February, according to a survey produced by the British Retail Consortium and KPMG. The data shows that non-food materially outperformed the food category, says Shore Capital analyst Clive Black. Subsequently, Black expects to issue "material downgrades" to his estimates for Morrison in the near future.

-------

FTSE 250 - WINNERS

Inchcape, up 2.9%. The car retailer's pretax profit rose in 2013, driven by higher like-for-like sales, an Australian acquisition and cost cutting, and it raised its dividend by 20%. Pretax profit rose to GBP266.1 million, up 7.4% from GBP247.7 million in 2012, as revenues rose to GBP6.52 billion, from GBP6.09 billion. It boosted its final dividend to 11.7 pence a share, resulting in a total dividend for 2013 of 17.4 pence per share, higher than the 14.5 pence per share paid last year.

Close Brothers, up 2.6%. The firm has reported increased half-year pretax profit, driven by its banking division's increased lending to commercial and retail borrowers, while its securities and asset management divisions also delivered growth. It made a GBP94.8 million pretax profit in the six months ended January 31, compared with GBP78.0 million in the corresponding period in the previous year, driven by a 14% rise in operating income to GBP322.0 million.

-------

FTSE 250 - LOSERS

African Barrick Gold, down 15%. Canadian gold producer Barrick Gold Corp said Tuesday it has completed the sale of 41 million shares, representing 10% of the issued share capital of ABG, while entering a lock-up agreement for its remaining holding for the next 120 days. Following the transaction, Barrick's holding in ABG has been reduced to 63.9%.

Fenner, down 6.1%. The polymer products manufacturer has seen its shares fall after it confirmed that its results for the first half of its current financial year will, as previously highlighted, be below those it recorded in the first half of fiscal 2013.

Computacenter, down 3.4%. The group's share price has dropped despite raising its total dividend for 2013 and reporting an increase in revenue for the year. While group revenue rose to GBP3.07 billion, up from GBP2.91 billion in 2012, the company posted a pretax profit of GBP50.5 million, down sharply from the GBP64.8 million recorded in the previous year, as it was hit by exceptional costs of GBP27.1 million.

Esure Group, down 1.9%. The motor and home insurer reported a marginally larger annual pretax profit, but said the costs of severe weather events in the first quarter of the new year are likely to cost GBP3.0 million to GBP4.0 million more than expected. Furthermore, while Shore Capital analyst Eamonn Flanagan believes that the company has "undoubted income attractions," he believes that a 11.5x price-earnings ratio for 2014 is "much too aggressive." Flanagan also expects all of the motor insurers, including esure, to react negatively to the Financial Conduct Authority's proposed shake-up of the GBP1 billion insurance add-on markets.

-------

AIM - WINNERS

Plethora Solutions Holdings, up 31%. The biotechnology company said it was in negotiations with a number of potential marketing partners for its premature ejaculation treatment PSD 502. It said that it is making "excellent progress" with its preferred manufacturing partner, and that it had received expressions of interest from several potential marketing partners for out-licensing PSD 502 in the US, EU and other territories. The company also said that, following its meeting with the US Food and Drug Administration in the first quarter, the FDA had confirmed that premature ejaculation is an area of "high medical need".

Ceres Power Holdings, up 14%. The low-cost fuel cell technology firm has signed a joint development agreement with a wholly-owned subsidiary of power firm Cummins PLC. It said the agreement with Cummins Power Generation would see the firms work together on a non-exclusive basis to combine their technical capabilities. The companies said further stages of the agreement could include a combined system feasibility project, as well development programmes with end-users and utilities, noting that successful completion of the initial joint venture could result in a broader co-operative development programme.

Empresaria Group, up 10%. The recruitment firm posted an increase in profit and revenue for the full year, boosted by a strong performance from its UK division. It posted pretax profit of GBP4.9 million for 2013, up from GBP3.6 million in 2012, as revenue rose slightly to GBP194.4 million, from GBP194.3 million a year earlier. Empresaria also announced an acquisition in the Middle East.

Deltex Medical Group, up 8.8%. The company has reported that its 2013 pretax loss came in at GBP2.2 million, unchanged from the figure reported in 2012, while revenues rose to GBP7.2 million, up from the GBP6.8 million reported in 2012, driven by sales of its surgical probes in 2013. The company also has launched a new training aide, an oesophageal Doppler patient simulator.

Share, up 7.2%. The company, which owns investment site The Share Centre, said 2013 pretax profit more than doubled, boosted by heightened investor interest after the initial public offering of Royal Mail PLC and by historically low interest rates driving savers to equity markets in the search for yield.

CloudBuy, up 7.1%. The firm said it has been awarded a contract in India to provide a cloudBuy private purchasing portal for electronic payments. It said the contract with Sarth Surfacrete builds on its investments in the country, after boosting its capabilities to cover India's range of in-country taxes in its eCommerce engine.

-------

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
19 Nov 2013 08:07

AIM IN BRIEF: Centamin Further Reduces Stake In Nyota Minerals

Read more
30 Sep 2013 13:34

Plethora Cuts Losses As It Focuses Entirely Premature Ejaculation Treatment

Read more
23 Sep 2013 12:12

UK WINNERS & LOSERS: Ariana Resources Stands Out From Weak Gold Miners

Read more
20 Sep 2013 13:06

MARKET COMMENT: UK Trades Flat Prior To US Open; Nyota, Plethora Lead AIM

Read more
20 Sep 2013 12:43

Plethora Solutions Premature Ejaculation Spray Gets Positive Opinion

Read more
20 Sep 2013 12:26

UPDATE 1-New Roche breast cancer drug wins backing in Europe and Japan

* Kadcyla approved in Japan, recommended for approval in EU * EU agency also backs Algeta/Bayer prostate cancer drug LONDON, Sept 20 (Reuters) - Roche's new breast cancer drug Kadcyla was approved in Japan on Friday and recommended for approval in Europe, building on February's U.S. g

Read more
12 Apr 2013 11:50

Plethora Solutions Chairman resigns

Plethora Solutions Holdings Chairman Bill Robinson is stepping down from his role at the pharmaceuticals company. Jim Mellon will take over as Chairman with immediate effect temporarily until a successor is found. Robinson, who has been Chairman since 2009, will remain a Non-Executive Director of

Read more
18 Mar 2013 14:25

Plethora Solutions secures much needed financing

Plethora Solutions has secured 2.1m pounds in funding after its subsidiary The Urology Co. fell into administration. The funds were raised through the placing of 106.2m new ordinary shares at a price of 2.0p per share, representing an 8.0% interest. It comes after the company announced it was in

Read more
14 Feb 2013 08:24

Plethora Solutions shares jump following new equity update

Shares in pharmaceuticals company Plethora Solutions jumped sharply on Thursday after the group reported that it was in 'advanced discussions' with an investor to provide new equity financing to the group. The group, whose share price had recently been declining, added that support was also being s

Read more
5 Feb 2013 11:07

Plethora Solutions shares plunge on urgent financing talks

Plethora Solutions is in urgent discussions with third parties to finance the company's working capital purposes. Shares in the pharmaceutical company plummeted 55.00% to 2.25p at 11:18 following Tuesday's announcement. The company said it remained focused on the development of SD502, a drug for

Read more
17 Oct 2012 15:15

Plethora's PSD502 drug has mass market potential

Plethora Solutions is definitely a small cap stock to watch and in an exclusive interview with Sharecast, Daniel Stewart analyst Vadim Alexandre has reiterated the bull case for the biotech tiddler. Plethora Solutions has a drug, PSD502, aimed at treating premature ejaculation, which has passed two

Read more
15 Mar 2012 12:06

Small caps round-up: HMV, Corero, ANGLE ...

HMV Group, the struggling entertainment media seller, has confirmed that it is still pondering what to do with its live music business. HMV added that a number of parties have indicated an interest in acquiring the business. There has been press speculation recently about who might be interested in

Read more
14 Mar 2011 17:36

Plethora's testosterone boost

AIM-quoted sexual health products developer and distributor Plethora Solutions has added the pan-European rights for testosterone replacement treatment Striant SR to the UK rights it already has. Plethora has secured the rights from Columbia Laboratories and it will sell the product through its di

Read more
7 Sep 2010 13:48

Small caps round-up: Charlemagne, Highams, Hydro...

Hedge fund manager Charlemagne's assets under management rise have picked up in the past two months to stand at $3.04bn at end August. The modest recovery follows a fall in the first half to $2.8bn, blamed on declining markets. Operating profits were $1.2m, down from $1.3m, with one-off performanc

Read more
19 Jul 2010 07:25

Plethora Solutions Launches New Product, hi-Argenol >PLE.LN

LONDON (Dow Jones)--Plethora Solutions Holdings PLC (PLE.LN), a U.K.-based specialty pharmaceutical company, said Monday it has launched a new product, hi-Argenol, for the maintenance and improvement of male sexual health. -Shares closed Friday at 11.75 pence valuing the company at GBP5.21 milli

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.